Versant Capital Management’s ArriVent BioPharma AVBP Stock Holding History

Versant Capital Management’s Portfolio AVBP Stock Details AVBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.7K	Hold	423	–	–	﹤0.01%	2083
2026 Q1	$9.76K	Buy	423 +10	+2%	+$226	﹤0.01%	2151
2025 Q4	$8.31K	Buy	413 +223	+117%	+$4.64K	﹤0.01%	2073
2025 Q3	$3.51K	Sell	190 -186	-49%	-$3.65K	﹤0.01%	2316
2025 Q2	$8.19K	Buy	+376	New	+$7.81K	﹤0.01%	1976

Other funds holding AVBP

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Torren Management San Diego, California $197M AUM

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return